As of 2025-12-22, the Relative Valuation of Gritstone Oncology Inc (GRTS) is (63.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Gritstone Oncology Inc based on Relative Valuation is -197399.2%.
The range of the Relative Valuation is (56.55) - (62.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.7x | 21.4x |
| Forward P/E multiples | 21.5x - 32.4x | 27.0x |
| Fair Price | (56.55) - (62.23) | (63.53) |
| Upside | -175731.0% - -193359.4% | -197399.2% |
| Date | P/E |